A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

NCT02734524 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: NK cells
DRUG: Taxol
DRUG: Carboplatin

Sponsor

Southwest Hospital, China